Cerus Corp
NASDAQ:CERS

Watchlist Manager
Cerus Corp Logo
Cerus Corp
NASDAQ:CERS
Watchlist
Price: 2.13 USD -15.81% Market Closed
Market Cap: $409.2m

Relative Value

The Relative Value of one CERS stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.13 USD, Cerus Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CERS Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

CERS Competitors Multiples
Cerus Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cerus Corp
NASDAQ:CERS
409m USD 1.8 -25.6 -46.7 -40
JP
Hoya Corp
TSE:7741
9.5T JPY 10.4 38 27.5 33
US
Medline Inc
NASDAQ:MDLN
58.3B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
31.8B CHF 3.9 41.8 16 31
DK
Coloplast A/S
CSE:COLO B
104.6B DKK 3.8 26.5 13.8 16.5
US
Align Technology Inc
NASDAQ:ALGN
13B USD 3.2 31.8 13.8 19
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.2 -17.5 18 58.3
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 2.6 36.8 14.6 24.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
40.7B CNY 9 24.8 22.4 22.4
JP
Asahi Intecc Co Ltd
TSE:7747
851.7B JPY 6.6 48.1 22.7 30.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
5B USD 3.3 21.5 13.7 16.8
P/E Multiple
Earnings Growth PEG
US
Cerus Corp
NASDAQ:CERS
Average P/E: 33.7
Negative Multiple: -25.6
N/A N/A
JP
Hoya Corp
TSE:7741
38
13%
2.9
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
41.8
32%
1.3
DK
Coloplast A/S
CSE:COLO B
26.5
22%
1.2
US
Align Technology Inc
NASDAQ:ALGN
31.8
34%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.5 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
36.8
41%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.8
9%
2.8
JP
A
Asahi Intecc Co Ltd
TSE:7747
48.1
37%
1.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
21.5
33%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Cerus Corp
NASDAQ:CERS
Average EV/EBITDA: 18.1
Negative Multiple: -46.7
N/A N/A
JP
Hoya Corp
TSE:7741
27.5
12%
2.3
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
16
9%
1.8
DK
Coloplast A/S
CSE:COLO B
13.8
6%
2.3
US
Align Technology Inc
NASDAQ:ALGN
13.8
15%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
18
29%
0.6
UK
ConvaTec Group PLC
LSE:CTEC
14.6
13%
1.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.4
13%
1.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
22.7
11%
2.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
13.7
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Cerus Corp
NASDAQ:CERS
Average EV/EBIT: 28.1
Negative Multiple: -40
N/A N/A
JP
Hoya Corp
TSE:7741
33
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
31
27%
1.1
DK
Coloplast A/S
CSE:COLO B
16.5
7%
2.4
US
Align Technology Inc
NASDAQ:ALGN
19
21%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
58.3
74%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
24.9
33%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.4
11%
2
JP
A
Asahi Intecc Co Ltd
TSE:7747
30.9
N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
16.8
32%
0.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett